Genomics into health
As genomic experts, we have a comprehensive understanding of how innovative technologies can contribute to more effective healthcare
We work with policy-makers, clinicians, academia and industry to develop future-focused healthcare strategies for safe and suitable use of innovations, such as diagnostics, genome editing and regenerative medicines. Only through understanding the benefits - and complexities - of genomics-based innovations and other 'omics sciences can we help everyone benefit from great science.
Policy briefing CAR-T cell therapies
CAR-T cell therapies are a form of cellular immunotherapy that use genetically modified T cells, a type of white blood cell.
Blog Genome UK: new four nations commitments to priority actions
18 March 2022
New commitments for UK-wide implementation of genomics have been announced that aim to accelerate research and drive healthcare innovation.
Blog Using genomics to improve drug prescribing
4 April 2022
A recent joint report has outlined guidance, barriers and opportunities around the use of pharmacogenomics.
Report Our healthy future
What do we want our healthy future to look like, and how can we ensure science helps our path towards that future?
Blog Goldacre recommendations for making the most of health data for research
8 April 2022
The Goldacre review, 'Better, broader, safer: using health data for research and analysis' is a hard-hitting report with recommendations for enabling the proper use of NHS health and care data for research , to drive improvements in health and care
Blog Urgent policy priorities for cancer
7 April 2022
The House of Commons Health and Social Care Committee released a report warning NHS targets for early diagnosis of cancer will not be met.
Explainer Vaccinomics
1 November 2021
What is vaccinomics?
Report Control of patient information in the COVID-19 era
25 October 2021
The control of patient information (COPI) notices have had significant positive impacts on COVID-19 - related research, but the success of future reforms to the use of CPI relies on building trustworthiness.
Blog Host genomics and COVID-19: where are we now?
25 October 2021
COVID-19 can have severe effects on even apparently low-risk individuals, and it has become clear that host factors affecting the risk of infection and disease progression include genomics.
Explainer Host genomics and infectious disease
22 September 2021
Genomic factors can explain why different people (hosts) may have more or less severe symptoms or no symptoms when infected by the same pathogen.
Blog Building a healthier future
6 September 2021
In an uncertain world - with new challenges to health - healthcare needs to adapt. Leveraging the power of new technologies, radical approaches to improving health will emerge.